Deka Bank Deutsche Girozentrale G1 Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$10.16 - $16.17 $476,504 - $758,373	-46,900 Closed	0 $0
Q4 2020 Mar 12, 2021	BUY	$10.99 - $20.4 $373,660 - $693,600	34,000 Added 263.57%	46,900 $845,000
Q3 2020 Oct 29, 2020	BUY	$11.55 - $23.75 $148,995 - $306,375	12,900 New	12,900 $150,000
Q3 2019 Nov 14, 2019	SELL	$22.78 - $40.58 $428,264 - $762,904	-18,800 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$16.03 - $31.1 $117,019 - $227,030	7,300 Added 63.48%	18,800 $585,000
Q1 2019 May 10, 2019	BUY	$14.4 - $21.45 $30,240 - $45,045	2,100 Added 22.34%	11,500 $691,000
Q4 2018 Feb 12, 2019	SELL	$16.51 - $51.33 $34,671 - $107,793	-2,100 Reduced 18.26%	9,400 $180,000
Q3 2018 Nov 09, 2018	SELL	$43.15 - $67.97 $12,945 - $20,391	-300 Reduced 2.54%	11,500 $0
Q1 2018 May 03, 2018	BUY	$19.05 - $41.76 $224,790 - $492,768	11,800 New	11,800 $423,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.